BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31790004)

  • 1. Clinical significance of endothelial progenitor cells in patients with liver cirrhosis with or without hepatocellular carcinoma.
    Cho HC; Kim JH; Cha RR; Kim WS; Lee JM; Lee SS; Kim HJ; Lee CM; Kim HJ; Ha CY; Kim TH; Jung WT; Lee OJ
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):87-94. PubMed ID: 31790004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
    Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low circulating level of CD133+KDR+cells in patients with systemic sclerosis.
    Mok MY; Yiu KH; Wong CY; Qiuwaxi J; Lai WH; Wong WS; Tse HF; Lau CS
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S19-25. PubMed ID: 21050541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.
    Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Jannini E; Lenzi A; Giugliano D
    J Sex Med; 2009 Jan; 6(1):107-14. PubMed ID: 19170841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.
    Maiorino MI; Bellastella G; Petrizzo M; Della Volpe E; Orlando R; Giugliano D; Esposito K
    Endocrine; 2015 Jun; 49(2):415-21. PubMed ID: 25411101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.
    Jung C; Rafnsson A; Shemyakin A; Böhm F; Pernow J
    Int J Cardiol; 2010 Sep; 143(3):368-72. PubMed ID: 19398138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma.
    Yang B; Gu W; Peng B; Xu Y; Liu M; Che J; Geng J; Zheng J
    J Urol; 2012 Dec; 188(6):2055-61. PubMed ID: 23088990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues.
    Yamaguchi R; Yano H; Nakashima Y; Ogasawara S; Higaki K; Akiba J; Hicklin DJ; Kojiro M
    Oncol Rep; 2000; 7(4):725-9. PubMed ID: 10854533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma.
    Yu D; Sun X; Qiu Y; Zhou J; Wu Y; Zhuang L; Chen J; Ding Y
    Clin Cancer Res; 2007 Jul; 13(13):3814-24. PubMed ID: 17606712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy.
    Osto E; Castellani C; Fadini GP; Baesso I; Gambino A; Agostini C; Avogaro A; Gerosa G; Thiene G; Iliceto S; Angelini A; Tona F
    J Heart Lung Transplant; 2011 Jan; 30(1):70-6. PubMed ID: 20817567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
    Ho JW; Pang RW; Lau C; Sun CK; Yu WC; Fan ST; Poon RT
    Hepatology; 2006 Oct; 44(4):836-43. PubMed ID: 17006919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis.
    Zahran AM; Abdel-Rahim MH; Refaat A; Sayed M; Othman MM; Khalak LMR; Hetta HF
    Acta Oncol; 2020 Jan; 59(1):33-39. PubMed ID: 31478425
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelial progenitor cells in patients with chronic obstructive pulmonary disease.
    Brittan M; Hoogenboom MM; Padfield GJ; Tura O; Fujisawa T; Maclay JD; Macnee W; Mills NL
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L964-9. PubMed ID: 24142520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating endothelial progenitor cell levels in treated hypertensive patients].
    Maroun-Eid C; Ortega-Hernández A; Abad M; García-Donaire JA; Barbero A; Reinares L; Martell-Claros N; Gómez-Garre D
    Hipertens Riesgo Vasc; 2015; 32(4):142-50. PubMed ID: 26486462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma.
    Yu DC; Chen J; Sun XT; Zhuang LY; Jiang CP; Ding YT
    BMC Cancer; 2010 Aug; 10():435. PubMed ID: 20716344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
    Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
    Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of pro-angiogenic factors and their receptors on angiogenesis in hepatocellular carcinoma].
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Li JJ; Gu JR; Guo BL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):472-5. PubMed ID: 15555336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.